Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Health
Related: About this forumLife, Death and Insulin
Source: Washington Post
Life, Death and Insulin
As the cost of the lifesaving medication skyrockets, some desperate diabetics are rationing and risking their lives. Was Alec Raeshawn Smith one of them?
Story by Tiffany Stanley
JANUARY 7, 2019
-snip-
Today, critics argue that the price of insulin has far outpaced any innovations. In the past decade alone, U.S. insulin list prices have tripled, according to an analysis of data from IBM Watson Health. In 1996, when Eli Lilly debuted its Humalog brand of insulin, the list price of a 10-milliliter vial was $21. The price of the same vial is now $275. Those costs can be compounded by the multiple vials that diabetics may require to survive each month. Its a very big problem, says Robert Gabbay, chief medical officer at the Joslin Diabetes Center in Boston. Its a tragic barrier to care.
The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. All three have raised list prices to similar levels. According to IBM Watson Health data, Sanofis popular insulin brand Lantus was $35 a vial when it was introduced in 2001; its now $270. Novo Nordisks Novolog was priced at $40 in 2001, and as of July 2018, its $289.
In Washington, the soaring price of insulin has provoked bipartisan concern. Members of Congress are trying to parse the factors that have caused the spike. In November, a congressional caucus released a report on insulin, urging legislation aimed at lowering prices through increased competition and pricing transparency, among other recommendations. In June, the American Medical Association called on the government to monitor insulin pricing and market competition and take enforcement actions as appropriate. Insulin, in some ways, serves as a proxy for the rising prices across the U.S. prescription drug market. On the campaign trail in 2016, Donald Trump railed against high drug prices, and his administration has vowed to lower them, releasing a flurry of proposals in the past year.
In the meantime, a portion of the more than 7 million diabetic Americans who take insulin are stuck with debilitating costs. Though most dont pay the full list price for insulin because of insurance coverage and other rebates, some do, especially those who are uninsured, underinsured or facing a coverage gap through Medicare. The most vulnerable patients are subsidizing the system, William Cefalu, the chief scientific, medical and mission officer of the American Diabetes Association, told a Senate committee in May.
-snip-
As the cost of the lifesaving medication skyrockets, some desperate diabetics are rationing and risking their lives. Was Alec Raeshawn Smith one of them?
Story by Tiffany Stanley
JANUARY 7, 2019
-snip-
Today, critics argue that the price of insulin has far outpaced any innovations. In the past decade alone, U.S. insulin list prices have tripled, according to an analysis of data from IBM Watson Health. In 1996, when Eli Lilly debuted its Humalog brand of insulin, the list price of a 10-milliliter vial was $21. The price of the same vial is now $275. Those costs can be compounded by the multiple vials that diabetics may require to survive each month. Its a very big problem, says Robert Gabbay, chief medical officer at the Joslin Diabetes Center in Boston. Its a tragic barrier to care.
The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. All three have raised list prices to similar levels. According to IBM Watson Health data, Sanofis popular insulin brand Lantus was $35 a vial when it was introduced in 2001; its now $270. Novo Nordisks Novolog was priced at $40 in 2001, and as of July 2018, its $289.
In Washington, the soaring price of insulin has provoked bipartisan concern. Members of Congress are trying to parse the factors that have caused the spike. In November, a congressional caucus released a report on insulin, urging legislation aimed at lowering prices through increased competition and pricing transparency, among other recommendations. In June, the American Medical Association called on the government to monitor insulin pricing and market competition and take enforcement actions as appropriate. Insulin, in some ways, serves as a proxy for the rising prices across the U.S. prescription drug market. On the campaign trail in 2016, Donald Trump railed against high drug prices, and his administration has vowed to lower them, releasing a flurry of proposals in the past year.
In the meantime, a portion of the more than 7 million diabetic Americans who take insulin are stuck with debilitating costs. Though most dont pay the full list price for insulin because of insurance coverage and other rebates, some do, especially those who are uninsured, underinsured or facing a coverage gap through Medicare. The most vulnerable patients are subsidizing the system, William Cefalu, the chief scientific, medical and mission officer of the American Diabetes Association, told a Senate committee in May.
-snip-
Read more: https://www.washingtonpost.com/news/magazine/wp/2019/01/07/feature/insulin-is-a-lifesaving-drug-but-it-has-become-intolerably-expensive-and-the-consequences-can-be-tragic/
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
3 replies, 1177 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (14)
ReplyReply to this post
3 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Life, Death and Insulin (Original Post)
Eugene
Jan 2019
OP
MaryMagdaline
(6,855 posts)1. This is frightening
My friend, who is an endocrinologist, regularly gives samples away to poor patients. They shouldnt have to depend on whether he has extras or not. They should be covered.
Blue Owl
(50,454 posts)2. Another sign that deplorables are in charge
sinkingfeeling
(51,469 posts)3. I bought Eli Lilly insulin for my Samoyed for almost 6 years.
She took Lente twice a day until they stopped making it. Then went on Humalog and occasionally regular. My dog didn't have insurance, but did get a Walgreens discount card. My girl has been gone since 2009.
I know several pet owners who purchase Lantus for their pooches.
The cost more than doubled during the time I purchased it monthly.